Capital Research Global Investors Insulet Corp Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Insulet Corp stock. As of the latest transaction made, Capital Research Global Investors holds 7,562,093 shares of PODD stock, worth $1.56 Billion. This represents 0.3% of its overall portfolio holdings.

Number of Shares

7,562,093

Previous 9,476,623 20.2%

Holding current value

$1.56 Billion

Previous $2.06 Billion 36.97%

% of portfolio

0.3%

Previous 0.52%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$163.6 - $209.11 $313 Million - $400 Million	-1,914,530 Reduced 20.2%	7,562,093 $1.3 Billion
Q4 2023 Feb 13, 2024	BUY	$127.77 - $221.42 $199 Million - $345 Million	1,556,455 Added 19.65%	9,476,623 $2.06 Billion
Q3 2023 Nov 13, 2023	BUY	$154.67 - $290.89 $425 Million - $800 Million	2,748,828 Added 53.16%	7,920,168 $1.26 Billion
Q2 2023 Aug 11, 2023	SELL	$272.48 - $330.23 $107 Million - $129 Million	-390,886 Reduced 7.03%	5,171,340 $1.49 Billion
Q1 2023 May 15, 2023	SELL	$276.36 - $326.03 $163 Million - $192 Million	-589,135 Reduced 9.58%	5,562,226 $1.77 Billion

Q4 2022 Feb 14, 2023	SELL	$212.22 - $313.46 $64.5 Million - $95.3 Million	-304,124 Reduced 4.71%	6,151,361 $1.81 Billion
Q3 2022 Nov 14, 2022	SELL	$224.6 - $281.45 $64.6 Million - $80.9 Million	-287,549 Reduced 4.26%	6,455,485 $1.48 Billion
Q2 2022 Aug 15, 2022	SELL	$186.4 - $279.02 $34.8 Million - $52.1 Million	-186,598 Reduced 2.69%	6,743,034 $1.47 Billion
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $172 Million - $243 Million	-881,880 Reduced 11.29%	6,929,632 $1.85 Billion
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $148 Million - $185 Million	579,764 Added 8.02%	7,811,512 $2.08 Billion
Q3 2021 Nov 15, 2021	BUY	$260.36 - $307.27 $89.6 Million - $106 Million	343,978 Added 4.99%	7,231,748 $2.06 Billion
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $275 Million - $371 Million	1,220,372 Added 21.53%	6,887,770 $1.89 Billion
Q1 2021 May 14, 2021	BUY	$235.95 - $293.05 $5.44 Million - $6.76 Million	23,058 Added 0.41%	5,667,398 $1.48 Billion
Q4 2020 Feb 12, 2021	SELL	$215.97 - $265.89 $35.6 Million - $43.8 Million	-164,720 Reduced 2.84%	5,644,340 $1.44 Billion
Q3 2020 Nov 13, 2020	SELL	$192.55 - $236.59 $3.06 Million - $3.75 Million	-15,868 Reduced 0.27%	5,809,060 $1.37 Billion
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $174 Million - $245 Million	-1,091,074 Reduced 15.78%	5,824,928 $1.13 Billion
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $30.2 Million - $50.2 Million	231,911 Added 3.47%	6,916,002 $1.15 Billion
Q4 2019 Feb 18, 2020	SELL	$144.81 - $186.0 $50.4 Million - $64.8 Million	-348,276 Reduced 4.95%	6,684,091 $1.14 Billion
Q3 2019 Nov 14, 2019	BUY	$117.35 - $167.95 $208 Million - $298 Million	1,772,336 Added 33.69%	7,032,367 $1.16 Billion
Q2 2019 Aug 14, 2019	SELL	$82.13 - $120.73 $690,795 - $1.02 Million	-8,411 Reduced 0.16%	5,260,031 $628 Million
Q1 2019 May 15, 2019	BUY	$72.44 - $101.87 $70.8 Million - $99.6 Million	977,623 Added 22.78%	5,268,442 $501 Million
Q4 2018 Feb 14, 2019	BUY	$73.27 - $105.19 $7.47 Million - $10.7 Million	102,005 Added 2.44%	4,290,819 $340 Million
Q3 2018 Nov 14, 2018	SELL	$81.43 - $108.13 $33.7 Million - $44.8 Million	-413,919 Reduced 8.99%	4,188,814 $444 Million
Q2 2018 Aug 14, 2018	SELL	$83.27 - $101.93 $46.7 Million - $57.2 Million	-561,222 Reduced 10.87%	4,602,733 $394 Million
Q1 2018 May 15, 2018	SELL	$68.49 - $87.2 $36.3 Million - $46.2 Million	-529,945 Reduced 9.31%	5,163,955 $448 Million
Q4 2017 Feb 14, 2018	SELL	$55.67 - $71.8 $18.2 Million - $23.5 Million	-327,733 Reduced 5.44%	5,693,900 $393 Million
Q3 2017 Nov 14, 2017	BUY	$49.68 - $59.46 $299 Million - $358 Million	6,021,633	6,021,633 $332 Million

Others Institutions Holding PODD

# of Institutions

614

Shares Held

62.9M

Call Options Held

339K

Put Options Held

916K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $14.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Insulet Corp Transaction History